266 related articles for article (PubMed ID: 26349993)
1. MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson's disease mouse.
Wang ZH; Zhang JL; Duan YL; Zhang QS; Li GF; Zheng DL
Biomed Pharmacother; 2015 Aug; 74():252-6. PubMed ID: 26349993
[TBL] [Abstract][Full Text] [Related]
2. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
Su C; Yang X; Lou J
Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998
[TBL] [Abstract][Full Text] [Related]
3. Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression.
Zhang QS; Wang ZH; Zhang JL; Duan YL; Li GF; Zheng DL
Biomed Pharmacother; 2016 Oct; 83():153-159. PubMed ID: 27470562
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA NEAT1 mediates the toxic of Parkinson's disease induced by MPTP/MPP+ via regulation of gene expression.
Liu Y; Lu Z
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):841-848. PubMed ID: 29575151
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.
Chen Y; Lian YJ; Ma YQ; Wu CJ; Zheng YK; Xie NC
Neurotoxicology; 2018 Sep; 68():212-221. PubMed ID: 29217406
[TBL] [Abstract][Full Text] [Related]
6. LincRNA-p21 Inhibits Cell Viability and Promotes Cell Apoptosis in Parkinson's Disease through Activating α-Synuclein Expression.
Xu X; Zhuang C; Wu Z; Qiu H; Feng H; Wu J
Biomed Res Int; 2018; 2018():8181374. PubMed ID: 30671473
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
8. Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: Reciprocal up-regulation of E6-AP and down-regulation of α-synuclein.
Ham A; Kim DW; Kim KH; Lee SJ; Oh KB; Shin J; Mar W
Brain Res; 2013 Aug; 1524():54-61. PubMed ID: 23751361
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP
Wu KC; Liou HH; Lee CY; Lin CJ
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of α-synuclein via SIRT1-deacetylated LC3.
Guo YJ; Dong SY; Cui XX; Feng Y; Liu T; Yin M; Kuo SH; Tan EK; Zhao WJ; Wu YC
Mol Nutr Food Res; 2016 Oct; 60(10):2161-2175. PubMed ID: 27296520
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease.
Sun Q; Zhang Y; Wang S; Yang F; Cai H; Xing Y; Zhou L; Chen S; Wang Y
Exp Cell Res; 2022 Aug; 417(1):113132. PubMed ID: 35398161
[TBL] [Abstract][Full Text] [Related]
12. miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
Geng L; Zhang T; Liu W; Chen Y
Neurosci Lett; 2018 May; 675():23-30. PubMed ID: 29567426
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.
Kabaria S; Choi DC; Chaudhuri AD; Mouradian MM; Junn E
FEBS Lett; 2015 Jan; 589(3):319-25. PubMed ID: 25541488
[TBL] [Abstract][Full Text] [Related]
14. MiR-302b-5p enhances the neuroprotective effect of IGF-1 in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease by regulating inducible nitric-oxide synthase.
Cui X; Li M; He Z; Hu L; Liu J; Yan J; Hua L
Cell Biochem Funct; 2020 Dec; 38(8):1025-1035. PubMed ID: 32474958
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
[TBL] [Abstract][Full Text] [Related]
18. miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models.
Tao X; Zhang W; Chen C; Tao Y; Tao Y; Chen Z; Zhang G
Aging (Albany NY); 2024 May; 16(10):8732-8746. PubMed ID: 38775730
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging.
Lu KT; Ko MC; Chen BY; Huang JC; Hsieh CW; Lee MC; Chiou RY; Wung BS; Peng CH; Yang YL
J Agric Food Chem; 2008 Aug; 56(16):6910-3. PubMed ID: 18616261
[TBL] [Abstract][Full Text] [Related]
20. Moracenin D from Mori Cortex radicis protects SH-SY5Y cells against dopamine-induced cell death by regulating nurr1 and α-synuclein expression.
Ham A; Lee HJ; Hong SS; Lee D; Mar W
Phytother Res; 2012 Apr; 26(4):620-4. PubMed ID: 21936000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]